Biotech / Medical
Juno Therapeutics Inc. (JUNO)
An SI Board Since May 2015
Posts SubjectMarks Bans Symbol
82 21 0 JUNO
Emcee:  scaram(o)uche Type:  Moderated
Not going to be boring, cell-based cancer immunotherapies.

There have been JUNO-related posts accumulating in other threads. A search will find them. Figured it was time for a devoted thread. Today's story? The Editas deal is supposed to reveal JUNO weakness relative to Cellectis (CLLS), that "allogeneic" has a competitive advantage.

That's today's story. A giant land-grab, deals between innovators flying amok, with a focus on IP that will surface in about three years. It's like 1995, all over again. Heavenly.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
82Class action attorneys are out looking for shareholders who don't feel they scaram(o)uche2January 22
81$87/share Good. CELG shareholders may not be happy.scaram(o)uche-January 22
80 Dana Mattioli?Verified account @DanaMattioli14m14 minutes ago Back-to-back dscaram(o)uche-January 16
79A preview of tomorrow's data, today..... pbs.twimg.comscaram(o)uche-12/10/2017
78Today's drop attributed to unconfirmed rumors of Celgene being uninterested tuck-11/28/2017
77ASH abstracts out, and the JCAR017 study called TRANSCEND has produced results Jtuck-11/1/2017
76But you may recall talk of offering it with a money back guarantee (oversimplifituck-10/20/2017
75RSI(14) stands at 54.87, bullish crossover in Stochastics. [graphic]hollyhunter-10/19/2017
74>> list price of $373k << Very good. Step in right direction. Thscaram(o)uche-10/18/2017
73Kite's CAR-T therapy approved about six weeks before PDUFA date with a REMS tuck-10/18/2017
72Any thoughts on price target for Juno? Does anyone else see Juno being acquired?bio kid-10/2/2017
71link should be secure, juno vs. kite, thanks to @sesiegler.....
70Gilead - Kite deal stokes buying in Juno Therapeutics, up 8% premarket CAR-T devJulius Wong-8/28/2017
69how to deal with patient crises and deaths in these fragile patient populations tuck-6/13/2017
68Since my March post, I have traded Juno put sales regularly and done well. Howetuck-6/13/2017
67PDUFA data in ALL for NVS' CAR-T therapy is in August. Juno has a small pietuck13/30/2017
66Leucid Bio Ltd. is an early stage competitor going after solid tumors with CAR-Ttuck-3/8/2017
65Thanks for your thoughts. >>I also note that RBC thinks the JUNO pre-condtuck-3/4/2017
64Nice comments, tuck. I really never got into it here, but I will comment brieflBiotech Jim-3/4/2017
63I picked up my third tranche today, wanted to maintain my basis under 22. I kBiotech Jim-3/3/2017
62We got another chance here. I doubled my sold put position. Cheers, Tucktuck-3/3/2017
61Parking the Juno and Kite pipelines here so followers can compare. Kite Pipe tuck23/2/2017
60Done buying JUNO shares for now, that was a huge no-brainer. Biotechs blow ouBiotech Jim13/2/2017
59I was too stingy this am in pre-market, as I was sweating the pennies. Finally Biotech Jim-3/2/2017
58Trying to pick up shares pre-market, but no many sellers. Very interesting confBiotech Jim-3/2/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.